Data center AI chip startup Ceremorphic has opened a life sciences division to search out and bring to market drugs based on a new technology platform, BioCompDiscoverX. The platform includes a heterogeneous accelerator partly based on analog silicon, which accelerates the emulation of human cells and tissues as part of the drug discovery process. The company aims to identify better candidate molecules from the start of the process, thereby bringing new drugs to market faster and cheaper.

https://www.eetimes.com/ai-chip-startup-ceremorphic-moves-into-drug-discovery/